Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Champlin

Showing results (31-40 of 279) with videos related to

Pageof 28
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigensR Champlin, R L Hunter
Blood|June 1, 1989
Acute lymphoblastic leukemia: recent advances in biology and therapyR Champlin, R P Gale
Blood|June 1, 1987
Acute myelogenous leukemia: recent advances in therapyR Champlin, R P Gale
Veterinary Research Communications|December 30, 1998
Adaptive acquisition of novobiocin resistance in Pasteurella multocida strains of avian originM Arif, F R Champlin
Antimicrobial Agents and Chemotherapy|September 1, 1988
Susceptibility to hydrophobic molecules and phospholipid composition in Pasteurella multocida and Actinobacillus lignieresiiM E Hart, F R Champlin
Veterinary Microbiology|June 15, 2007
Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosanMatthew L Ellison, Franklin R Champlin
Applied and Environmental Microbiology|June 1, 1979
Noninvolvement of beauvericin in the entomopathogenicity of Beauveria bassianaF R Champlin, E A Grula
Journal of Medical Microbiology|July 20, 2017
Cell surface physiology and outer cell envelope impermeability for hydrophobic substances in Burkholderia multivoransSallie A Ruskoski, Franklin R Champlin
Cancer Treatment and Research|May 9, 2000
Non myeloablative "mini transplants"S Giralt, I Khouri, R Champlin
Pediatric Transplantation|December 10, 1999
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modalityR Champlin, I Khouri, S Giralt
Pageof 28

Showing results (31-40 of 279) with videos related to

Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigensR Champlin, R L Hunter
Blood|June 1, 1989
Acute lymphoblastic leukemia: recent advances in biology and therapyR Champlin, R P Gale
Blood|June 1, 1987
Acute myelogenous leukemia: recent advances in therapyR Champlin, R P Gale
Veterinary Research Communications|December 30, 1998
Adaptive acquisition of novobiocin resistance in Pasteurella multocida strains of avian originM Arif, F R Champlin
Antimicrobial Agents and Chemotherapy|September 1, 1988
Susceptibility to hydrophobic molecules and phospholipid composition in Pasteurella multocida and Actinobacillus lignieresiiM E Hart, F R Champlin
Veterinary Microbiology|June 15, 2007
Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosanMatthew L Ellison, Franklin R Champlin
Applied and Environmental Microbiology|June 1, 1979
Noninvolvement of beauvericin in the entomopathogenicity of Beauveria bassianaF R Champlin, E A Grula
Journal of Medical Microbiology|July 20, 2017
Cell surface physiology and outer cell envelope impermeability for hydrophobic substances in Burkholderia multivoransSallie A Ruskoski, Franklin R Champlin
Cancer Treatment and Research|May 9, 2000
Non myeloablative "mini transplants"S Giralt, I Khouri, R Champlin
Pediatric Transplantation|December 10, 1999
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modalityR Champlin, I Khouri, S Giralt
Pageof 28